Category: Joint ventures/collaborations
-
Pharma Companies Form $1B Antibiotics Fund
A group of 23 pharmaceutical companies are creating an investment fund to finance research and development of new drugs to combat antibiotic resistance.
-
Virtual Drug Discovery Incubator Launched for Univ. Labs
Life science investors and a drug discovery company started a remote business incubator service to discover and develop early therapy candidates from academic research.
-
Open-Source N95 Respirator Mask in the Works
An engineering partnership is designing a 3-D printed medical face mask needed by front-line health care workers, with its specifications soon to be made freely available.
-
Program Reduces Long-Term Care Covid-19 Outbreaks
A collaborative program between an academic medical center and long-term care homes for older residents helps reduce Covid-19 infection outbreaks and deaths.
-
Engineered Immune, Stem Cells Studied for HIV Cure
Academic and industry researchers are investigating engineered immune-system cells combined with stem cells as an immunotherapy to neutralize HIV viruses and cure infections.
-
Partnership to Speed Covid-19 Clinical Trials
A company that aims to accelerate clinical trials is partnering with an entrepreneur and researcher to speed up the pace of new trials of Covid-19 vaccines, therapies, and diagnostics.
-
Biotechs Partner on Crispr for Stem Cell Transplants
A biotechnology partnership is evaluating a synthetic antibody to make it safer for people with genetic diseases to receive gene-edited bone marrow stem-cell transplants.
-
Covid-19 Vaccine for Lower-Income Regions Underway
Researchers in the U.K. designed a vaccine to prevent Covid-19 infections and is starting an enterprise to make it available to lower-income countries.
-
Industry, Univ. Labs Partner on Covid-19 Therapy
Researchers from industry and academic labs are developing a synthetic antibody that in lab tests shows promise as both a Covid-19 therapy and vaccine.
-
MD Anderson to Advance Laser Immunotherapy
An experimental cancer treatment that uses lasers to activate drugs that invoke the immune system is being evaluated by MD Anderson Cancer Center.